menu
    • menu

    Company profile for Xenon Pharmaceuticals Inc

    NEW Drugs in Dev: 11
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Xenon is focused on developing innovative therapeutics to improve the lives of patients with neurological disorders. Our goal is to build a self-sustaining, fully-integrated, and profitable company that discovers, develops and commercializes innovative CNS therapeutics, including novel, selective ion channel modulators. We intend to expand our pipeline with therapeutic candidates from our internal research efforts and through ...
    Xenon is focused on developing innovative therapeutics to improve the lives of patients with neurological disorders. Our goal is to build a self-sustaining, fully-integrated, and profitable company that discovers, develops and commercializes innovative CNS therapeutics, including novel, selective ion channel modulators. We intend to expand our pipeline with therapeutic candidates from our internal research efforts and through the acquisition or in-licensing of other technologies or product candidates.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Xenon Pharmaceuticals IncCanada Flag
    Country
    Country
    Canada
    Address
    Address
    3650 Gilmore Way Burnaby, BC V5G 4W8
    Telephone
    Telephone
    +6044843300
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.xenon-pharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/xenon-pharmaceuticals-inc-/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BePharma

    Not Confirmed

    envelop Contact Supplier

    BePharma

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Xenon Pharma Closes $747.5M Upsized Offering on Full Option
    Xenon Pharma Closes $747.5M Upsized Offering on Full Option

    12 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/12/3255083/33485/en/Xenon-Pharmaceuticals-Announces-Closing-of-747-5-Million-Upsized-Public-Offering-Including-Full-Exercise-of-the-Underwriters-Option-to-Purchase-Additional-Shares.html

    GLOBENEWSWIRE
    12 Mar 2026
    Share Share
    Xenon Seeks FDA Approval for Epilepsy Drug After Phase 3 Win
    Xenon Seeks FDA Approval for Epilepsy Drug After Phase 3 Win

    10 Mar 2026

    // BIOSPACE

    https://www.biospace.com/drug-development/xenon-to-seek-approval-of-first-in-class-epilepsy-drug-after-exceeding-phase-3-expectations

    BIOSPACE
    10 Mar 2026
    Share Share
    Xenon Pharmaceuticals Announces Proposed Public Offering
    Xenon Pharmaceuticals Announces Proposed Public Offering

    09 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/09/3252288/33485/en/Xenon-Pharmaceuticals-Announces-Proposed-Public-Offering.html

    GLOBENEWSWIRE
    09 Mar 2026
    Share Share
    Xenon Reports Q4 and Full Year 2025 Financial Results and Update
    Xenon Reports Q4 and Full Year 2025 Financial Results and Update

    26 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/26/3246061/33485/en/Xenon-Reports-Q4-and-Full-Year-2025-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    26 Feb 2026
    Share Share
    Xenon Pharma Discloses Inducement Grants Per Nasdaq LR 5635(C)(4)
    Xenon Pharma Discloses Inducement Grants Per Nasdaq LR 5635(C)(4)

    16 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/16/3220553/33485/en/Xenon-Pharmaceuticals-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    16 Jan 2026
    Share Share
    Xenon Highlights 2026 Milestones At J.P. Morgan Health Conference
    Xenon Highlights 2026 Milestones At J.P. Morgan Health Conference

    12 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/12/3216905/33485/en/Xenon-Outlines-Key-Upcoming-Milestones-at-the-2026-J-P-Morgan-Healthcare-Conference.html

    GLOBENEWSWIRE
    12 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search